{
  "id": 10395196,
  "title": "Sebi Opens The IPO Door For Three Companies, Pioneer Fil-Med, Tonbo Imaging And Functional & Innovative Foods Get The Nod",
  "url": "https://urgent.news/2026/09/28/sebi-opens-the-ipo-door-for-three-companies-pioneer-fil-med-tonbo",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-09-28T07:37:30.000Z",
  "source": {
    "name": "Free Press Journal",
    "slug": "free-press-journal",
    "url": "https://www.freepressjournal.in/business/sebi-opens-the-ipo-door-for-three-companies-pioneer-fil-med-tonbo-imaging-and-functional-innovative-foods-get-the-nod"
  },
  "original_language": "en",
  "account": "Mumbai: Sebi granted approval to three companies, Pioneer Fil-Med, Tonbo Imaging India, and Functional & Innovative Foods, to move forward with their planned initial public offerings (IPOs). The regulator's feedback on the draft offer documents was issued between September 21 and 25, as reported on Monday. While this clearance is a crucial milestone in the IPO process, the companies still need to satisfy all necessary conditions before proceeding with their share offerings. Food contract manufacturer Functional & Innovative Foods is targeting a fresh issue of up to 60 lakh shares and an OFS of up to 25 lakh shares. The company aims to establish manufacturing units in Namakkal, Tamil Nadu, and Dhar, Madhya Pradesh, while repaying certain debts and meeting long-term working capital requirements.",
  "summary": "Mumbai: Pioneer Fil-Med , Tonbo Imaging India and Functional & Innovative Foods have received Sebi’s observations on their draft offer documents, allowing the three companies to advance their proposed initial public offerings (IPOs). The capital markets regulator issued its observations between September 21 and 25, according to an update released on Monday. The clearance is a key step in the IPO…",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}